BeStock  
Stocks › Cancer Research › BIIB

Biogen BIIB

US equityMarket cap rank #410Cancer Research
$225.08 −$0.81 (-0.36%)
Market open · Oct 1, 1:20 pm ET · After hours $225.88 0.00%
Open$225.50
Prev close$225.88
Day range$224.19 – $228.31
Volume599.0K
Market cap$33.26B
P/E (TTM)40.0
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$2.74B+3.4% YoY
Operating profit$482.80M-43.3% YoY
Net profit$97.50M-84.6% YoY
Diluted EPS$0.66-84.8% YoY
Free cash flow$308.00M+129.3% YoY
Operating cash flow$448.90M

Revenue, last 8 quarters

$2.5BSep '24$2.5BDec '24$2.4BMar '25$2.6BJun '25$2.5BSep '25$2.3BDec '25$2.5BMar '26$2.7BJun '26

Net profit, last 8 quarters

$388.5MSep '24$266.7MDec '24$240.5MMar '25$634.8MJun '25$466.5MSep '25$-48.9MDec '25$319.5MMar '26$97.5MJun '26

Diluted EPS by quarter

2.66Sep '241.83Dec '241.64Mar '254.33Jun '253.17Sep '25-0.33Dec '252.15Mar '260.66Jun '26

Free cash flow by quarter

$805.6MSep '24$694.6MDec '24$212.2MMar '25$134.3MJun '25$1.2BSep '25$401.7MDec '25$559.3MMar '26$308.0MJun '26

Annual revenue

$13.4BFY20$11.0BFY21$10.2BFY22$9.8BFY23$9.7BFY24$9.9BFY25

Profitability & balance sheet

Gross margin74.0%
Operating margin19.3%
Net margin8.3%
Return on equity4.6%
Return on assets2.8%
Return on invested capital3.7%
Current ratio1.87
Liabilities / assets41.3%
Cash & investments$1.29B
Total debt$8.36B
Net cash (debt)-$7.07B
Free cash flow / sales24.8%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $2.74B $2.48B $9.89B $2.28B $2.53B
Total Operating Revenue $2.74B $2.48B $9.89B $2.28B $2.53B
Cost of Revenue $776.90M $661.00M $2.40B $495.50M $674.40M
Gross Profit $1.96B $1.82B $7.49B $1.78B $1.86B
Operating Expense $1.48B $1.36B $5.02B $1.40B $1.25B
Selling and Admin Expenses $709.70M $607.30M $2.43B $682.50M $594.80M
Research & Development $529.60M $539.00M $1.78B $509.40M $436.10M
Depreciation & Amortization & Depletion $168.20M $136.50M $515.00M $136.60M $135.70M
-Depreciation & Amortization $168.20M $136.50M $515.00M $136.60M $135.70M
Other Operating Expenses $68.80M $74.20M $290.20M $69.90M $87.20M
Operating Profit $482.80M $459.80M $2.47B $385.50M $606.50M
Net Non-Operating Interest Income (Expense) -$57.00M -$29.70M -$142.50M -$30.30M -$35.80M
Non-Operating Interest Income $25.30M $37.90M $125.00M $37.20M $31.60M
Non-Operating Interest Expense $82.30M $67.60M $267.50M $67.50M $67.40M
Other Income (Expense) -$293.40M -$52.40M -$770.00M -$411.20M -$13.40M
Gain on Sale of Security $35.10M $15.80M -$48.30M $2.70M -$14.10M
Special Income (Charges) -$331.50M -$67.10M -$746.40M -$426.60M -$15.10M
-Less:Restructuring and Mergern & Acquisition $167.90M $28.40M $82.20M $11.80M $13.00M
-Less:Other Special Charges $163.60M $38.70M $611.30M $361.90M $2.10M
Other Non-Operating Income (Expenses) $3.00M -$1.10M $24.70M $12.70M $15.80M
Pretax Profit $132.40M $377.70M $1.56B -$56.00M $557.30M
Tax $34.90M $58.20M $263.60M -$7.10M $90.80M
Net Profit $97.50M $319.50M $1.29B -$48.90M $466.50M
Profit from Continuing Operations $97.50M $319.50M $1.29B -$48.90M $466.50M
Net Income to Parent Company $97.50M $319.50M $1.29B -$48.90M $466.50M
Net Income to Common Stockholders $97.50M $319.50M $1.29B -$48.90M $466.50M
Basic EPS $0.66 $2.17 $8.83 -$0.33 $3.18
Diluted EPS $0.66 $2.15 $8.79 -$0.33 $3.17
-Less:Impairment of Capital Assets – – $52.90M – –
Minority Interests – – $0.00 – –
-Gain on Sale of Property/Plant/Equipment – – – – $0.00

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $32.09B $29.48B $29.44B $29.44B $29.21B
Total Current Assets $7.31B $9.19B $8.97B $8.97B $8.94B
Cash and Cash Equivalents & Short-Term Investments $1.29B $4.28B $3.82B $3.82B $3.96B
-Cash and Cash Equivalents $1.29B $3.38B $3.01B $3.01B $3.86B
-Short Term Investments $0.00 $900.00M $807.20M $807.20M $97.60M
Receivables $2.40B $1.79B $1.87B $1.87B $1.85B
-Accounts Receivable $2.40B $1.79B $1.87B $1.87B $1.85B
Inventory $2.38B $1.95B $2.17B $2.17B $2.21B
Other Current Assets $1.24B $1.17B $1.12B $1.12B $916.80M
Total Non-Current Assets $24.78B $20.29B $20.47B $20.47B $20.27B
Net PPE $3.24B $3.27B $3.32B $3.32B $3.41B
-Gross PPE $3.24B $3.27B $6.25B $6.25B $6.27B
Investments and Advances $0.00 $465.60M $431.90M $431.90M –
Goodwill and Other Intangible Assets $20.51B $15.54B $15.67B $15.67B $15.82B
-Goodwill $6.99B $6.49B $6.49B $6.49B $6.49B
-Other Intangible Assets $13.52B $9.05B $9.18B $9.18B $9.33B
Non-Current Deferred Assets $202.10M $238.20M $292.50M $292.50M $312.40M
Other Non-Current Assets $831.80M $777.50M $750.60M $750.60M $729.70M
Total Liabilities $13.24B $10.83B $11.18B $11.18B $11.00B
Total Current Liabilities $3.92B $3.00B $3.35B $3.35B $3.29B
Payables $490.80M $452.10M $546.80M $546.80M $516.40M
-Accounts Payable $403.90M $358.50M $432.00M $432.00M $413.10M
-Total Tax Payable $86.90M $93.60M $114.80M $114.80M $103.30M
Current Accrued Expenses $2.24B $2.35B $2.43B $2.43B $2.37B
Short-Term Debt and Capital Lease Obligation $800.00M – – – –
-Current Debt $800.00M – – – –
Total Non-Current Liabilities $9.32B $7.83B $7.83B $7.83B $7.71B
Long Term Accounts Payable and Other Payables $177.50M $174.20M – – $164.70M
Long Term Debt and Capital Lease Obligation $7.56B $6.56B $6.58B $6.58B $6.59B
-Long Term Debt $7.29B $6.29B $6.29B $6.29B $6.29B
-Long Term Capital Lease Obligation $264.80M $273.40M $290.40M $290.40M $305.00M
Non-Current Deferred Liabilities $945.50M $483.50M $507.60M $507.60M $358.10M
Other Non-Current Liabilities $643.40M $612.90M $748.50M $748.50M $597.10M
Total Equity $18.85B $18.65B $18.26B $18.26B $18.21B
Stockholders' Equity $18.85B $18.65B $18.26B $18.26B $18.21B
Capital Stock $100,000.00 $100,000.00 $100,000.00 $100,000.00 $100,000.00
-Common Stock $100,000.00 $100,000.00 $100,000.00 $100,000.00 $100,000.00
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $983.00M $896.70M $863.10M $863.10M $797.70M
Retained Earnings $20.97B $20.87B $20.55B $20.55B $20.60B
Less: Treasury Stock $2.98B $2.98B $2.98B $2.98B $2.98B
Gains/Losses Not Affecting Retained Earnings -$127.70M -$140.20M -$182.00M -$182.00M -$214.80M
-Available for Sale Securities – $465.60M $431.90M $431.90M –
-Accumulated Depreciation – – -$2.93B -$2.93B -$2.87B
Other Current Liabilities – – – – $89.10M

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $448.90M $645.50M $2.20B $511.90M $1.27B
Net cash flow from continuing operations $448.90M $645.50M $2.20B $511.90M $1.27B
Net Income from Continuing Operations $97.50M $319.50M $1.29B -$48.90M $466.50M
Gain/Loss from Continuing Operations -$42.80M -$19.00M $19.30M -$14.40M $500,000.00
Depreciation & Depletion & Amortization $236.10M $204.40M $779.90M $200.20M $202.20M
Deferred Tax -$27.60M $23.60M $361.60M $166.90M $253.80M
Other Non-Cash Items $346.40M $160.90M $456.90M $199.90M $100.00M
Change in Working Capital -$238.10M -$127.90M -$1.06B -$108.70M $174.20M
-Change in Receivables -$223.90M $69.70M $42.10M -$21.00M $229.40M
-Change in Inventory $75.70M $116.20M -$64.70M -$29.40M -$7.40M
-Change in Payables and Accrued Expense -$49.70M -$243.20M $171.10M $203.80M $286.00M
-Change In Other Working Capital -$40.20M -$70.60M -$1.21B -$262.10M -$333.80M
Net cash flow from investing -$3.84B -$209.50M -$1.37B -$1.23B -$35.10M
Net Cash Flow from Continuing Investing Activities -$3.84B -$209.50M -$1.37B -$1.23B -$35.10M
Net PPE Purchase and Sale -$40.90M -$51.20M -$153.80M -$43.90M -$46.20M
Net Intangibles Purchase and Sale -$100.00M -$35.00M -$81.60M -$66.30M -$5.30M
Net Investment Purchase and Sale $1.37B -$123.10M -$1.18B -$1.14B -$34.40M
Net Other Investing Changes -$600,000.00 -$200,000.00 $42.90M $22.70M $50.80M
Financing Cash Flow $1.30B -$43.80M -$301.90M -$137.00M -$130.20M
Net Cash Flow from Continuing Financing Activities $1.30B -$43.80M -$301.90M -$137.00M -$130.20M
Proceeds from Stock Option Exercised $6.00M -$55.10M -$10.00M $3.00M $5.20M
Net Other Financing Charges -$13.30M $11.30M -$275.00M -$140.00M -$135.10M
Ending Cash Balance $1.29B $3.38B $3.01B $3.01B $3.86B
Net Change in Cash -$2.09B $392.20M $531.60M -$856.80M $1.11B
Beginning Cash Balance $3.38B $3.01B $2.38B $3.86B $2.76B
Effect of Exchange Rate Changes -$3.40M -$18.00M $101.90M $2.50M -$3.20M
Free Cash Flow $308.00M $559.30M $1.97B $401.70M $1.22B
Net Business Purchase and Sale – – $0.00 $0.00 $0.00
Net Issuance Payments Of Debt – – -$16.90M $0.00 -$300,000.00

Discussion

No comments yet — be the first to weigh in on BIIB.

Leave a comment

Scroll to Top